Blueprint Medicines Corporation

Go to Blueprint Medicines Corporation Website

$0.00

(%)
Live
Previous Close

$

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$6.0 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic diseas...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Zoetis (ZTS) reports better-than-expected first-quarter results, wherein both earnings and revenues beat estimates. Shares rise.

Related tickers: LGND, ZTS, BPMC, ANVS.

Read Full Article

Blueprint Medicines (BPMC) delivered earnings and revenue surprises of 19.51% and 16.40%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Related tickers: BPMC, MYGN.

Read Full Article
Trending Tickers
LASE

XNAS

$1.95
(%)
PACW

XNAS

$7.54
(%)
SMFL

XNAS

$3.20
(%)
SQ

XNYS

$66.84
(%)
MLGO

XNAS

$2.50
(%)